Clinical Trial: Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, >6 to <30 mm in Diameter, Determined by LDCT.

U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07168993) titled 'Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, >6 to 6 to <30 mm in Diameter, Determined by LDCT.

Study Start Date: Nov. 01

Study Type: INTERVENTIONAL

Condition: Lung Cancer (Diagnosis)

Intervention: OTHER: Standard medical treatment

Standard of care follow up per institution

OTHER: Standard medical treatment

SOC per institution

Recruitment Status: NOT_YET_RECRUITING

Sponsor: bioAffinity Technologies Inc.

Published by HT...